UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

           January 10, 2008           
(Date of earliest event reported)

LABORATORY CORPORATION OF
AMERICA HOLDINGS

---

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

ITEM 7.01. Regulation FD Disclosure

On January 10, 2008, Laboratory Corporation of America^® Holdings (LabCorp^®) (NYSE: LH), an industry leader in cancer testing, announced that it recognizes January, designated by the U.S. Congress as Cervical Health Awareness Month, as a time to highlight the issues surrounding cervical cancer and the importance of screening for women. Cervical cancer is one of the few cancers that can reliably be prevented through early detection and intervention. Recent medical and technological advancements have made it easier than ever for women to identify their risk for cervical cancer and receive the proper treatment.

Exhibits

99.1 Press Release dated January 10, 2008

---

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	Laboratory Corporation of America Holdings (Registrant)
Date: January 10, 2008	By:	/s/Bradford T. Smith
		Bradford T. Smith, Executive Vice President and Secretary